Liberate Medical is a medical device company based in Crestwood, Ky that develops neuromuscular electrical stimulation technology to improve care and reduce costs for patients with pulmonary disorders. Its lead product, VentFree Respiratory Muscle Stimulator, is the only non-invasive, breath-synchronized neuromuscular electrical stimulator intended to prevent expiratory muscle atrophy in mechanically ventilated patients. VentFree has FDA Breakthrough Device Designation, FDA Emergency Use Authorization, and CE marking in the European Union, and follows two successful pilot randomized controlled trials in Europe and Australia. The company plans to use Series B proceeds to support the pivotal PREVENT trial, which aims to show VentFree reduces duration of invasive mechanical ventilation in patients at risk of being difficult to wean. Liberate intends that reduced ventilation time will lower risks such as hospital-acquired infections, deteriorated quality of life, and death. The funding is also intended to support preparations for FDA regulatory clearance and a full commercial launch of VentFree.

Total raised

$6M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2023